health benefits of glp-1 agonists The conversation around medications is growing, and it goes beyond the number on the scale. According to the American Heart Association, evidence suggests GLP-1s may support heart and help reduce GLP-1 Medications Infographic | Medidex

We currently have dulaglutide, liraglutide and sc semaglutide with approved CV indication (see Table 1)

Because DPP-4 inhibitors work in a glucose-dependent manner, they do not usually cause hypoglycemia

While preclinical data are promising, more clinical trials are needed to assess their efficacy and safety in diverse neuropathic pain populations

As a result, regulatory approval was restricted to Type 2 diabetes management rather than obesity [2729]

GLP-1 transport across the blood brain barrier (BBB) Several lines of evidence indicate that peripherally administered GLP-1 can cross the blood brain barrier (BBB)

Reproduction (2017) 153(6):R187204